Insulin Pump Therapy and Continuous Glucose Monitoring (Oxford Diabetes Library)

ISBN 10: 019956860X / ISBN 13: 9780199568604

Edité par OUP Oxford, 2009

A propos de cet article

Our good condition books are generally good for reading but not for gifting or collecting. They could have imperfections such as creasing, fanning, inscriptions, margin notes, yellowing, staining on edge or cover or pages, bumps, scuffs, etc etc (sometimes multiple of these). It's a wide category that encompasses anything that isn't almost-new down to anything that is slightly better than poor. We would NOT recommend gifting Good books - these should be considered reading copies. Our books are dispatched from a Yorkshire former cotton mill. We list via barcode/ISBN so please note that the images are stock images and may not be the exact copy you receive, furthermore the details about edition and year might not be accurate as many publishers reuse the same ISBN for multiple editions and as we simply scan a barcode or enter an ISBN we do not check the validity of the edition data when listing. If you're looking for an exact edition please don't order (at least not without checking with us first, although we don't always have time to check). We aim to dispatch prompty, the service used will depend on order value and book size. We can ship to most countries, see our shipping policies. Payment is via Abe only.

N° de réf. du vendeur mon0000004155

Détails bibliographiques

• Titre: Insulin Pump Therapy and Continuous Glucose Monitoring (Oxford Diabetes Library)
• Éditeur: OUP Oxford
• Date de parution: 2009
• Langue: anglais
• ISBN à 10 chiffres: 019956860X
• ISBN à 13 chiffres: 9780199568604
• Reliure: paperback
• État de l'article: Good

A propos de ce titre

Synopsis

Insulin pump therapy, or continuous subcutaneous insulin infusion (CSII), has evolved from a research procedure in the 1970s to a routine form of treatment for selected people with type 1 diabetes. This book is the first to combine a detailed discussion of the evidence-base for all aspects of CSII in adults and children with a practical guide to treating people with diabetes using insulin pump therapy. It also includes a discussion on the clinical applications of continuous glucose monitoring (CGM), a technology which is increasingly being used with CSII, and best injection therapy for optimizing diabetes control. The book concludes with a look into the future with a discussion on likely developments in pump therapy and CGM in the coming years, including research into an artificial pancreas and completely non-invasive glucose sensing. The book is aimed specifically at doctors, nurses, dietitians and other healthcare professionals involved in setting up and running an Insulin Pump Service. Several national guidelines for insulin pump therapy have recently been issued, including from the UK National Institute for Health and Clinical Excellence (NICE). These extend the clinical indications to new groups of patients and underline the urgent need for physicians and other healthcare professionals to update themselves about CSII and to ensure improved access to insulin pump services for all eligible patient groups. This book meets that need. The book is edited by the originator of CSII and includes chapters by a well-established team responsible for one of the largest Insulin Pump Clinics in the UK, and with additional contributions from internationally acknowledged experts in insulin pump therapy, CGM and diabetes technology.

À propos de l?auteur

John Pickup is Professor of Diabetes and Metabolism at King's College London School of Medicine, Guy's Hospital, London, UK. He received both his DPhil and medical training at Oxford University, UK. He has a long-standing interest in the development and clinical application of novel technology for the improved management of diabetes, starting from the first development of insulin pump therapy through to in vivo glucose sensors. His current research focuses on insulin pump therapy and continuous glucose monitoring in clinical practice, developing fluorescence approaches to glucose sensing, and activation of the innate immune system and inflammation as a cause of type 2 diabetes. He has edited many previous award-winning books on diabetes, and is the recipient of several research awards, including the R D Lawrence Lectureship of the British Diabetic Association (Diabetes UK), the Gotch Prize of Oxford University, and the Boehringer Mannheim Fellowship of the Biochemical Society.